Avenue Therapeutics Statistics
Total Valuation
ATXI has a market cap or net worth of 2.34 million. The enterprise value is -2.21 million.
Market Cap | 2.34M |
Enterprise Value | -2.21M |
Important Dates
The next estimated earnings date is Wednesday, November 12, 2025.
Earnings Date | Nov 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ATXI has 3.18 million shares outstanding. The number of shares has increased by 367.20% in one year.
Current Share Class | 3.18M |
Shares Outstanding | 3.18M |
Shares Change (YoY) | +367.20% |
Shares Change (QoQ) | +7.16% |
Owned by Insiders (%) | 0.71% |
Owned by Institutions (%) | 3.15% |
Float | 2.83M |
Valuation Ratios
The trailing PE ratio is 0.66.
PE Ratio | 0.66 |
Forward PE | n/a |
PS Ratio | 1.67 |
PB Ratio | 0.83 |
P/TBV Ratio | 0.58 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.83 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.13
Current Ratio | 3.13 |
Quick Ratio | 3.10 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -185.46% and return on invested capital (ROIC) is -119.39%.
Return on Equity (ROE) | -185.46% |
Return on Assets (ROA) | -86.89% |
Return on Invested Capital (ROIC) | -119.39% |
Return on Capital Employed (ROCE) | -224.58% |
Revenue Per Employee | 702,000 |
Profits Per Employee | 1.34M |
Employee Count | 2 |
Asset Turnover | 0.31 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -76.87% in the last 52 weeks. The beta is -0.07, so ATXI's price volatility has been lower than the market average.
Beta (5Y) | -0.07 |
52-Week Price Change | -76.87% |
50-Day Moving Average | 0.45 |
200-Day Moving Average | 0.85 |
Relative Strength Index (RSI) | 73.01 |
Average Volume (20 Days) | 9,978 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 4.69 |
Income Statement
In the last 12 months, ATXI had revenue of 1.40 million and earned 2.67 million in profits. Earnings per share was 1.11.
Revenue | 1.40M |
Gross Profit | 1.40M |
Operating Income | -6.36M |
Pretax Income | -6.18M |
Net Income | 2.67M |
EBITDA | n/a |
EBIT | -6.36M |
Earnings Per Share (EPS) | 1.11 |
Balance Sheet
The company has 3.33 million in cash and n/a in debt, giving a net cash position of 3.33 million or 1.04 per share.
Cash & Cash Equivalents | 3.33M |
Total Debt | n/a |
Net Cash | 3.33M |
Net Cash Per Share | 1.04 |
Equity (Book Value) | 2.83M |
Book Value Per Share | 1.27 |
Working Capital | 2.83M |
Cash Flow
Operating Cash Flow | -5.02M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | 100.00% |
Operating Margin | -452.99% |
Pretax Margin | -439.81% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ATXI does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -367.20% |
Shareholder Yield | n/a |
Earnings Yield | 114.23% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on April 26, 2024. It was a reverse split with a ratio of 0.0133333.
Last Split Date | Apr 26, 2024 |
Split Type | Reverse |
Split Ratio | 0.0133333 |
Scores
ATXI has an Altman Z-Score of -37.75 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -37.75 |
Piotroski F-Score | 1 |